시장보고서

상품코드

1790282

대규모 및 소규모 바이오프로세스 시장 규모, 점유율, 동향 분석 보고서 : 규모별, 워크플로우별, 제품별, 사용 유형별, 모드별, 용도별, 지역별, 부문별 예측(2025-2033년)

Large And Small-scale Bioprocessing Market Size, Share & Trends Analysis Report By Scale, By Workflow, By Product, By Use Type, By Mode, By Application, By Region, And Segment Forecasts, 2025 - 2033

발행일: 2025년 07월 | 리서치사:

Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

대규모 및 소규모 바이오프로세스 시장 요약

대규모 및 소규모 바이오프로세스 세계 시장 규모는 2024년에 805억 달러로 평가되었습니다. 2033년에는 2,287억 달러에 달하고, 2025-2033년 11.86% 성장할 것으로 예측됩니다. 이 같은 성장은 주로 단일클론항체, 백신, 세포 및 유전자 치료제를 포함한 생물학적 제제에 대한 전 세계 수요 증가에 기인합니다.

바이오제약 기업들은 일회용 기술, 모듈식 바이오프로세싱 시스템 등 유연한 제조 솔루션에 많은 투자를 하고 있으며, 이는 개발 기간 단축과 제조 비용 절감에 기여하고 있습니다.

부문 대시보드
세계의 대규모 및 소규모 바이오프로세스 시장 제품별 변동 분석
세계의 대규모 및 소규모 바이오프로세스 시장 규모와 동향 분석(제품별, 2021-2033년)
바이오리액터/발효조
세포배양 제품
바이오리액터 액세서리
여과 어셈블리
백 및 용기
기타

제6장 대규모 및 소규모 바이오프로세스 시장 : 용도별 추정 및 동향 분석

부문 대시보드
세계의 대규모 및 소규모 바이오프로세스 시장 용도 변동 분석
세계의 대규모 및 소규모 바이오프로세스 시장 규모와 동향 분석(용도별, 2021-2033년)
바이오의약품
특수 산업용 화학제품
환경 보조

제7장 대규모 및 소규모 바이오프로세스 시장 : 사용 유형별 추정 및 동향 분석

부문 대시보드
세계의 대규모 및 소규모 바이오프로세스 시장 사용 유형별 변동 분석
세계의 대규모 및 소규모 바이오프로세스 시장 규모와 동향 분석(사용 유형별, 2021-2033년)
다목적
일회용

제8장 대규모 및 소규모 바이오프로세스 시장 : 모드별 추정 및 동향 분석

부문 대시보드
세계의 대규모 및 소규모 바이오프로세스 시장 모드별 변동 분석
세계의 대규모 및 소규모 바이오프로세스 시장 규모와 동향 분석(모드별, 2021-2033년)
바이오의약품
특수 산업용 화학제품
사내
아웃소싱

제9장 대규모 및 소규모 바이오프로세스 시장 : 워크플로우별 추정 및 동향 분석

부문 대시보드
세계의 대규모 및 소규모 바이오프로세스 시장 워크플로우별 변동 분석
대규모 및 소규모 바이오프로세스 시장 규모와 동향 분석(워크플로우별, 2021-2033년)
Downstream 처리
발효
Upstream 처리

제10장 대규모 및 소규모 바이오프로세스 시장 : 지역별 추정 및 동향 분석

지역별 시장 점유율 분석, 2024년 및 2033년
지역별 시장 대시보드
시장 규모, 예측 동향 분석, 2021-2033년 :
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제11장 경쟁 구도

기업/경쟁 분류
전략 매핑
기업 시장 현황 분석, 2024년
기업 개요/상장기업
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Danaher(Cytiva)
- Corning Inc.
- Sartorius AG
- CESCO BIOENGINEERING CO., LTD
- Bio-Process Group
- BPC Instruments AB
- Eppendorf AG
- Getinge AB
- Lonza
- PBS Biotech, Inc
- Bio-Synthesis, Inc.
- Meissner Filtration Products, Inc.
- Entegris
- KUHNER AG
- Saint-Gobain
- ExcellGene SA
- Repligen Corporation
- Avantor, Inc
- CerCell A/S
- Univercells Technologies
- Distek, Inc.
- F. Hoffmann-La Roche Ltd

LSH 25.08.25

Large And Small-scale Bioprocessing Market Summary

The global large and small-scale bioprocessing market size was estimated at USD 80.5 billion in 2024 and is expected to reach USD 228.7 billion by 2033, growing at a CAGR of 11.86% from 2025 to 2033. This substantial growth is primarily driven by the increasing global demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies.

Biopharmaceutical companies invest significantly in flexible manufacturing solutions, such as single-use technologies and modular bioprocessing systems, which help accelerate development timelines and reduce production costs.

Global Large And Small-Scale Bioprocessing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global large and small-scale bioprocessing market on the basis of scale, workflow, product, application, use type, mode, and region:

Scale Outlook (Revenue, USD Million, 2021 - 2033)
Industrial Scale (Over 50,000 Litres)
Small Scale (Less Than 50,000 Litres)
Workflow Outlook (Revenue, USD Million, 2021 - 2033)
Downstream Processing
Fermentation
Upstream Processing
Product Outlook (Revenue, USD Million, 2021 - 2033)
Bioreactors/Fermenters
Cell Culture Products
Filtration Assemblies
Bioreactors Accessories
Bags & Containers
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Biopharmaceuticals
Speciality Industrial Chemicals
Environmental Aids
Use Type Outlook (Revenue, USD Million, 2021 - 2033)
Multi-Use
Single-Use
Mode Outlook (Revenue, USD Million, 2021 - 2033)
In-house
Outsourced
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Scale
- 1.2.2. Workflow
- 1.2.3. Product
- 1.2.4. Application
- 1.2.5. Mode
- 1.2.6. Use Type
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Large and Small-Scale Bioprocessing Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing implementation of single-use technology (SUT) for bioproduction
  - 3.2.1.2. Rising demand for biologics
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High initial setup and operational costs for large-scale bioprocessing
  - 3.2.2.2. Complexity and regulatory hurdles
3.3. Large and small-scale bioprocessing Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis

Chapter 4. Large and Small-Scale Bioprocessing Market: Scale Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Large and Small-Scale Bioprocessing Market Scale Movement Analysis
4.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Scale, 2021 to 2033 (USD Million)
4.4. Industrial Scale (Over 50,000 Litre)
- 4.4.1. Industrial Scale (Over 50,000 Litre) market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Small Scale (Less Than 50,000 Litre)
- 4.5.1. Small Scale (Less Than 50,000 Litre) market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Large and Small-Scale Bioprocessing Market: Product Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Large and Small-Scale Bioprocessing Market Product Movement Analysis
5.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Bioreactors/Fermenters
- 5.4.1. Bioreactors/Fermenters market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. Cell Culture Products
- 5.5.1. Cell Culture Products market estimates and forecasts, 2021 to 2033 (USD Million)
5.6. Bioreactors Accessories
- 5.6.1. Bioreactors Accessories market estimates and forecasts, 2021 to 2033 (USD Million)
5.7. Filtration Assemblies
- 5.7.1. Filtration Assemblies market estimates and forecasts, 2021 to 2033 (USD Million)
5.8. Bags & Containers
- 5.8.1. Bags & Containers market estimates and forecasts, 2021 to 2033 (USD Million)
5.9. Others
- 5.9.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Large and Small-Scale Bioprocessing Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Large and Small-Scale Bioprocessing Market Application Movement Analysis
6.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Biopharmaceuticals
- 6.4.1. Biopharmaceuticals market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Speciality Industrial Chemicals
- 6.5.1. Speciality Industrial Chemicals market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Environmental Aids
- 6.6.1. Environmental Aids market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Large and Small-Scale Bioprocessing Market: Use Type Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Large and Small-Scale Bioprocessing Market Use Type Movement Analysis
7.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Use Type, 2021 to 2033 (USD Million)
7.4. Multi-Use
- 7.4.1. . Multi-Use market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. . Single-Use
- 7.5.1. Single-Use market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Large and Small-Scale Bioprocessing Market: Mode Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Global Large and Small-Scale Bioprocessing Market Mode Movement Analysis
8.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
8.4. . Biopharmaceuticals
- 8.4.1. Biopharmaceuticals market estimates and forecasts, 2021 to 2033 (USD Million)
8.5. Speciality Industrial Chemicals
- 8.5.1. Speciality Industrial Chemicals market estimates and forecasts, 2021 to 2033 (USD Million)
8.6. . In-House
- 8.6.1. In-House market estimates and forecasts, 2021 to 2033 (USD Million)
8.7. . Outsourced
- 8.7.1. Outsourced market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Large and Small-Scale Bioprocessing Market: Workflow Estimates & Trend Analysis

9.1. Segment Dashboard
9.2. Global Large and Small-Scale Bioprocessing Market Workflow Movement Analysis
9.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
9.4. Downstream Processing
- 9.4.1. Downstream Processing market estimates and forecasts, 2021 to 2033 (USD Million)
9.5. Fermentation
- 9.5.1. Fermentation market estimates and forecasts, 2021 to 2033 (USD Million)
9.6. Upstream Processing
- 9.6.1. Upstream Processing market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 10. Large and Small-Scale Bioprocessing Market: Regional Estimates & Trend Analysis

10.1. Regional Market Share Analysis, 2024 & 2033
10.2. Regional Market Dashboard
10.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
10.4. North America
- 10.4.1. U.S.
  - 10.4.1.1. Key country dynamics
  - 10.4.1.2. Regulatory Framework
  - 10.4.1.3. Competitive scenario
  - 10.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.4.2. Canada
  - 10.4.2.1. Key country dynamics
  - 10.4.2.2. Regulatory Framework
  - 10.4.2.3. Competitive scenario
- 10.4.3. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.4.4. Mexico
  - 10.4.4.1. Key country dynamics
  - 10.4.4.2. Competitive scenario
  - 10.4.4.3. Regulatory Framework
  - 10.4.4.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
10.5. Europe
- 10.5.1. UK
  - 10.5.1.1. Key country dynamics
  - 10.5.1.2. Competitive scenario
  - 10.5.1.3. Regulatory Framework
  - 10.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.2. Germany
  - 10.5.2.1. Key country dynamics
  - 10.5.2.2. Competitive scenario
  - 10.5.2.3. Regulatory Framework
  - 10.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.3. France
  - 10.5.3.1. Key country dynamics
  - 10.5.3.2. Competitive scenario
  - 10.5.3.3. France market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.4. Italy
  - 10.5.4.1. Key country dynamics
  - 10.5.4.2. Competitive scenario
  - 10.5.4.3. Regulatory Framework
  - 10.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.5. Spain
  - 10.5.5.1. Key country dynamics
  - 10.5.5.2. Competitive scenario
  - 10.5.5.3. Regulatory Framework
  - 10.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.6. Norway
  - 10.5.6.1. Key country dynamics
  - 10.5.6.2. Competitive scenario
  - 10.5.6.3. Regulatory Framework
  - 10.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.7. Sweden
  - 10.5.7.1. Key country dynamics
  - 10.5.7.2. Competitive scenario
  - 10.5.7.3. Regulatory Framework
  - 10.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.8. Denmark
  - 10.5.8.1. Key country dynamics
  - 10.5.8.2. Competitive scenario
  - 10.5.8.3. Regulatory Framework
  - 10.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
10.6. Asia Pacific
- 10.6.1. Japan
  - 10.6.1.1. Key country dynamics
  - 10.6.1.2. Competitive scenario
  - 10.6.1.3. Regulatory Framework
  - 10.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6.2. China
  - 10.6.2.1. Key country dynamics
  - 10.6.2.2. Competitive scenario
  - 10.6.2.3. Regulatory Framework
  - 10.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6.3. India
  - 10.6.3.1. Key country dynamics
  - 10.6.3.2. Competitive scenario
  - 10.6.3.3. Regulatory Framework
  - 10.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6.4. Australia
  - 10.6.4.1. Key country dynamics
  - 10.6.4.2. Competitive scenario
  - 10.6.4.3. Regulatory Framework
  - 10.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6.5. South Korea
  - 10.6.5.1. Key country dynamics
  - 10.6.5.2. Competitive scenario
  - 10.6.5.3. Regulatory Framework
  - 10.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6.6. Thailand
  - 10.6.6.1. Key country dynamics
  - 10.6.6.2. Competitive scenario
  - 10.6.6.3. Regulatory Framework
  - 10.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
10.7. Latin America
- 10.7.1. Brazil
  - 10.7.1.1. Key country dynamics
  - 10.7.1.2. Competitive scenario
  - 10.7.1.3. Regulatory Framework
  - 10.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.7.2. Argentina
  - 10.7.2.1. Key country dynamics
  - 10.7.2.2. Competitive scenario
  - 10.7.2.3. Regulatory Framework
  - 10.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
10.8. MEA
- 10.8.1. South Africa
  - 10.8.1.1. Key country dynamics
  - 10.8.1.2. Competitive scenario
  - 10.8.1.3. Regulatory Framework
  - 10.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.8.2. Saudi Arabia
  - 10.8.2.1. Key country dynamics
  - 10.8.2.2. Competitive scenario
  - 10.8.2.3. Regulatory Framework
  - 10.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.8.3. UAE
  - 10.8.3.1. Key country dynamics
  - 10.8.3.2. Competitive scenario
  - 10.8.3.3. Regulatory Framework
  - 10.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.8.4. Kuwait
  - 10.8.4.1. Key country dynamics
  - 10.8.4.2. Competitive scenario
  - 10.8.4.3. Regulatory Framework
  - 10.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 11. Competitive Landscape

11.1. Company/Competition Categorization
11.2. Strategy Mapping
11.3. Company Market Position Analysis, 2024
11.4. Company Profiles/Listing
- 11.4.1. Merck KGaA
  - 11.4.1.1. Company overview
  - 11.4.1.2. Financial performance
  - 11.4.1.3. Product benchmarking
  - 11.4.1.4. Strategic initiatives
- 11.4.2. Thermo Fisher Scientific, Inc.
  - 11.4.2.1. Company overview
  - 11.4.2.2. Financial performance
  - 11.4.2.3. Product benchmarking
  - 11.4.2.4. Strategic initiatives
- 11.4.3. Danaher (Cytiva)
  - 11.4.3.1. Company overview
  - 11.4.3.2. Financial performance
  - 11.4.3.3. Product benchmarking
  - 11.4.3.4. Strategic initiatives
- 11.4.4. Corning Inc.
  - 11.4.4.1. Company overview
  - 11.4.4.2. Financial performance
  - 11.4.4.3. Product benchmarking
  - 11.4.4.4. Strategic initiatives
- 11.4.5. Sartorius AG
  - 11.4.5.1. Company overview
  - 11.4.5.2. Financial performance
  - 11.4.5.3. Product benchmarking
  - 11.4.5.4. Strategic initiatives
- 11.4.6. CESCO BIOENGINEERING CO., LTD
  - 11.4.6.1. Company overview
  - 11.4.6.2. Financial performance
  - 11.4.6.3. Product benchmarking
  - 11.4.6.4. Strategic initiatives
- 11.4.7. Bio-Process Group
  - 11.4.7.1. Company overview
  - 11.4.7.2. Financial performance
  - 11.4.7.3. Product benchmarking
  - 11.4.7.4. Strategic initiatives
- 11.4.8. BPC Instruments AB
  - 11.4.8.1. Company overview
  - 11.4.8.2. Financial performance
  - 11.4.8.3. Product benchmarking
  - 11.4.8.4. Strategic initiatives
- 11.4.9. Eppendorf AG
  - 11.4.9.1. Company overview
  - 11.4.9.2. Financial performance
  - 11.4.9.3. Product benchmarking
  - 11.4.9.4. Strategic initiatives
- 11.4.10. Getinge AB
  - 11.4.10.1. Company overview
  - 11.4.10.2. Financial performance
  - 11.4.10.3. Product benchmarking
  - 11.4.10.4. Strategic initiatives
- 11.4.11. Lonza
  - 11.4.11.1. Company overview
  - 11.4.11.2. Financial performance
  - 11.4.11.3. Product benchmarking
  - 11.4.11.4. Strategic initiatives
- 11.4.12. PBS Biotech, Inc
  - 11.4.12.1. Company overview
  - 11.4.12.2. Financial performance
  - 11.4.12.3. Product benchmarking
  - 11.4.12.4. Strategic initiatives
- 11.4.13. Bio-Synthesis, Inc.
  - 11.4.13.1. Company overview
  - 11.4.13.2. Financial performance
  - 11.4.13.3. Product benchmarking
  - 11.4.13.4. Strategic initiatives
- 11.4.14. Meissner Filtration Products, Inc.
  - 11.4.14.1. Company overview
  - 11.4.14.2. Financial performance
  - 11.4.14.3. Product benchmarking
  - 11.4.14.4. Strategic initiatives
- 11.4.15. Entegris
  - 11.4.15.1. Company overview
  - 11.4.15.2. Financial performance
  - 11.4.15.3. Product benchmarking
  - 11.4.15.4. Strategic initiatives
- 11.4.16. KUHNER AG
  - 11.4.16.1. Company overview
  - 11.4.16.2. Financial performance
  - 11.4.16.3. Product benchmarking
  - 11.4.16.4. Strategic initiatives
- 11.4.17. Saint-Gobain
  - 11.4.17.1. Company overview
  - 11.4.17.2. Financial performance
  - 11.4.17.3. Product benchmarking
  - 11.4.17.4. Strategic initiatives
- 11.4.18. ExcellGene SA
  - 11.4.18.1. Company overview
  - 11.4.18.2. Financial performance
  - 11.4.18.3. Product benchmarking
  - 11.4.18.4. Strategic initiatives
- 11.4.19. Repligen Corporation
  - 11.4.19.1. Company overview
  - 11.4.19.2. Financial performance
  - 11.4.19.3. Product benchmarking
  - 11.4.19.4. Strategic initiatives
- 11.4.20. Avantor, Inc
  - 11.4.20.1. Company overview
  - 11.4.20.2. Financial performance
  - 11.4.20.3. Product benchmarking
  - 11.4.20.4. Strategic initiatives
- 11.4.21. CerCell A/S
  - 11.4.21.1. Company overview
  - 11.4.21.2. Financial performance
  - 11.4.21.3. Product benchmarking
  - 11.4.21.4. Strategic initiatives
- 11.4.22. Univercells Technologies
  - 11.4.22.1. Company overview
  - 11.4.22.2. Financial performance
  - 11.4.22.3. Product benchmarking
  - 11.4.22.4. Strategic initiatives
- 11.4.23. Distek, Inc.
  - 11.4.23.1. Company overview
  - 11.4.23.2. Financial performance
  - 11.4.23.3. Product benchmarking
  - 11.4.23.4. Strategic initiatives
- 11.4.24. F. Hoffmann-La Roche Ltd
  - 11.4.24.1. Company overview
  - 11.4.24.2. Financial performance
  - 11.4.24.3. Product benchmarking
  - 11.4.24.4. Strategic initiatives